0001360604HEALTHCARE REALTY TRUST INCORPORATEDS-3424B5EX-FILING FEESN/AN/Aiso4217:USD000136060412026-07-312026-07-3100013606042026-07-312026-07-31
Exhibit 107
Calculation of Filing Fee Tables

424(b)(5)
(Form Type)

Healthcare Realty Trust Incorporated
(Exact Name of Registrant as Specified in its Charter)

Table 1: Newly Registered and Carry Forward Securities

Security
Type
Security
Class
Title
Fee
Calculation
or Carry
Forward
Rule
Amount
Registered
Proposed
Maximum
Offering
Price Per
Unit
Maximum
Aggregate
Offering
Price
Fee
Rate
Amount of
Registration
Fee
Carry
Forward
Form
Type
Carry
Forward
File
Number
Carry
Forward
Initial
effective
date
Filing Fee
Previously
Paid In
Connection
with
Unsold
Securities
to be
Carried
Forward
Newly Registered Securities
Fees to Be Paid--------
Fees
Previously
Paid
-------
Carry Forward Securities
Carry
Forward
Securities
EquityClass A Common Stock, $0.01 par value per shareRule 415(a)(6)$1,000,000,000
S-3ASR
333-273784
8/8/2023
$116,350 (1)
Total Offering Amounts$1,000,000,000$0-
Total Fees Previously Paid $0
Total Fee Offsets $0
Net Fee Due $0

(1)Healthcare Realty Trust Incorporated (the “Company”) previously registered shares of common stock having an aggregate offering price of up to $750,000,000, offered by means of a prospectus supplement, dated March 5, 2021 (the “2021 Prospectus Supplement”), pursuant to the Company’s Registration Statement on Form S-3 (File No. 333-253600), filed with the Securities and Exchange Commission on February 26, 2021 (the “2021 Registration Statement”). In connection with the filing of the 2021 Prospectus Supplement, the Company made a contemporaneous fee payment to the SEC in the amount of $81,825. All such shares remained unsold and were carried forward to the Company’s Registration Statement on Form S-3 (File No. 333-273784), filed with the SEC on August 8, 2023 (the “2023 Registration Statement”) pursuant to Rule 415(a)(6). On December 17, 2025, the Company registered shares of common stock having an aggregate offering price of up to $1,000,000,000, offered by means of a prospectus supplement, dated December 17, 2025 (the “2025 Prospectus Supplement”), pursuant to the 2023 Registration Statement, of which shares having an aggregate offering price of $750,000,000 represented unsold securities previously registered pursuant to the 2021 Prospectus Supplement and the 2021 Registration Statement. In connection with the filing of the 2025 Prospectus Supplement, the Company made a contemporaneous fee payment in the amount of $34,525, reflecting the fee due with respect to shares of common stock to be offered and sold pursuant to the 2025 Prospectus Supplement that were not unsold securities registered pursuant to the 2021 Prospectus Supplement and the 2021 Registration Statement. Pursuant to Rule 415(a)(6) under the Securities Act, the securities with an aggregate offering price of $1,000,000,000 (collectively, the “Carry Forward Securities”) are unsold securities previously registered on the 2023 Registration Statement, for which filing fees of $116,350, in the aggregate, were previously paid to the Securities and Exchange Commission on the dates described above and will continue to be applied to such Carry Forward Securities. Pursuant to Rule 415(a)(6), the offering of the Carry Forward Securities under the 2023 Registration Statement was deemed terminated as of the immediate effectiveness of the Company's new registration statement on Form S-3ASR (File No. 333-297897) filed with the SEC on July 31, 2026. As a result, no additional filing fee is due.